John David Harris - Net Worth and Insider Trading

John David Harris Net Worth

The estimated net worth of John David Harris is at least $35 dollars as of 2024-06-06. John David Harris is the VP and GM Cell Therapy of Plus Therapeutics Inc and owns about 14 shares of Plus Therapeutics Inc (PSTV) stock worth over $35. Details can be seen in John David Harris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John David Harris has not made any transactions after 2016-08-10 and currently still holds the listed stock(s).

Transaction Summary of John David Harris

To

John David Harris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John David Harris owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .

Click here to see the complete history of John David Harris’s form 4 insider trades.

Insider Ownership Summary of John David Harris

Ticker Comapny Transaction Date Type of Owner
PSTV Plus Therapeutics Inc 2016-08-10 VP and GM of Cell Therapy

John David Harris Latest Holdings Summary

John David Harris currently owns a total of 1 stock. John David Harris owns 14 shares of Plus Therapeutics Inc (PSTV) as of August 10, 2016, with a value of $35.

Latest Holdings of John David Harris

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTV Plus Therapeutics Inc 2016-08-10 14 2.51 35

Holding Weightings of John David Harris


John David Harris Form 4 Trading Tracker

According to the SEC Form 4 filings, John David Harris has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 5 shares on August 10, 2016, which cost John David Harris around $5,075.

Insider Trading History of John David Harris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John David Harris Trading Performance

GuruFocus tracks the stock performance after each of John David Harris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John David Harris is -14.72%. GuruFocus also compares John David Harris's trading performance to market benchmark return within the same time period. The performance of stocks bought by John David Harris within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John David Harris's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John David Harris

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.57 LIMIT LIMIT LIMIT LIMIT LIMIT

John David Harris Ownership Network

Ownership Network List of John David Harris

No Data

Ownership Network Relation of John David Harris

Insider Network Chart

John David Harris Owned Company Details

What does Plus Therapeutics Inc do?

Who are the key executives at Plus Therapeutics Inc?

John David Harris is the VP and GM of Cell Therapy of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .

Plus Therapeutics Inc (PSTV) Insider Trades Summary

Over the past 18 months, John David Harris made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 27,261 shares made by Robert P Lenk , a net purchase of 20,297 shares made by Howard Clowes , and a net purchase of 32,255 shares made by Greg Petersen .

In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 48,285 shares, with a net purchase of 48,285 shares. During the past 18 months, 3,568 shares of Plus Therapeutics Inc (PSTV) were sold and 103,372 shares were bought by its insiders, resulting in a net purchase of 99,804 shares.

Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Plus Therapeutics Inc Insider Transactions

No Available Data

John David Harris Mailing Address

Above is the net worth, insider trading, and ownership report for John David Harris. You might contact John David Harris via mailing address: 3020 Callan Road, San Diego Ca 92121.

Discussions on John David Harris

No discussions yet.